Technical Analysis for HTGX - Hercules Technology Growth Capital, Inc. 6.25% Notes due 2024

Grade Last Price % Change Price Change
grade D 25.05 -0.04% -0.01
HTGX closed down 0.04 percent on Friday, February 1, 2019, on 11 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Flat Flat
See historical HTGX trend table...

Date Alert Name Type % Chg
Feb 1 Narrow Range Bar Range Contraction 0.00%
Feb 1 Inside Day Range Contraction 0.00%
Jan 31 Shooting Star Candlestick Bearish -0.04%
Jan 31 Lizard Bearish Bearish Day Trade Setup -0.04%
Jan 31 Outside Day Range Expansion -0.04%
Jan 30 Narrow Range Bar Range Contraction -0.20%
Jan 30 NR7 Range Contraction -0.20%
Jan 30 Gapped Up Strength -0.20%
Jan 29 Shooting Star Candlestick Bearish 0.04%
Jan 29 50 DMA Support Bullish 0.04%

Older signals for HTGX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Hercules Technology Growth Capital, Inc. is a private equity, venture capital, and venture debt firm specializing in providing capital to privately held venture capital and private equity backed companies and select publicly-traded companies. It seeks to provide emerging growth capital with focus on first institutional round (Series A/B). The firm also invests in expansion stage with focus on follow-on rounds of growth capital (Series B-F). It provides seed and early stage financing. It provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition; convertible, subordinated and/or mezzanine loans; domestic and international expansion; growth capital term loans; vendor financing; revenue acceleration by sales and marketing development and manufacturing expansion. It also provides asset-based financing with a focus on cash flow-based customized financing solutions; accounts receivable facilities; equipment loans/leases; equipment; acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory; equipment and infrastructure financing; and facilities build-out and/or expansion. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It offers growth and emerging growth capital and structured debt financing to companies at all stages of development and specializes in venture debt in the forms of senior secured and subordinated working capital loans, senior revolving loans and bridge loans, venture leasing, and select direct equity capital. It also provides private equity financing for recapitalizations, leveraged buyouts, spin-off transactions, mergers and acquisitions, public to private financings, and PIPEs. It invests in debt and equity investments in later stage, venture, and in special opportunities in the lower middle market companies. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. It primarily provides senior secured revolvers and term loans; unitranche and "one-stop" financings; and mezzanine debt, including "last-out" and second lien financings. The firm typically provides non-control financing solutions used for refinancing of existing indebtedness; acquisition financing – control buyouts and minority recaps. It prefers to invest in technology, energy technology, life sciences, and manufacturing sectors. Within technology it focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; healthcare services; information services; internet consumer and business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; fuels and power technology; geothermal; advanced materials (bio-chemicals, solar materials); carbon (capture, conversion, and abatement), energy efficiency technologies (smart grid, demand response, and lighting); generation (solar, biomass, bio fuels, and wind); recycling (conversion, diversion, and programs), storage (batteries, fuel cells), technology (management, measurement, controls), transportation (engine design, infrastructure), waste, and water (treatment, waste water, and desalination). Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It provides specialized energy technology industry financings with a focus on international special purpose entity financing; pilot and production facility financing; pre-commercialization facility financing; situation-specific financing (satisfying customer contract requirements, pre-funding strategic relationship, etc.); and supplemental joint venture financing. Within life sciences, it provided growth capital financing solutions with a focus on royalty-based financing of existing or future new drugs or medical devices. The firm invests in Israel and also considers investment in the Mid-Atlantic regions particularly in the areas of software, biotech and information services. It seeks to invest in companies with capital needs from $1 million to $30 million and revenues of $10 million to $200 million, generating EBITDA of $2 million to $15 million, focused primarily on business services, communications, electronics, hardware, and healthcare services. It also co-invests with other private equity firms. Hercules Technology Growth Capital, Inc. was founded in December 2003 and is based in Palo Alto, California with additional offices in San Diego, California; Boston, Massachusetts; Waltham, Massachusetts; Boulder, Colorado; Broomfield, Colorado; Costa Mesa, California; McLean, Virginia; Elmhurst, Illinois; Franklin Park, Illinois and New York, New York.
Transportation Biotechnology Corporate Finance Equity Securities Private Equity Electronics Chemicals Consumer Products Pharmaceuticals Semiconductors Drug Discovery Venture Capital Digital Media Mezzanine Capital Healthcare Services Colorado Energy Technology Enterprise Software Entrepreneurship Clean Technology Fuel Cells Biopharmaceuticals Leveraged Buyout Orix Usa Bio Chemicals Consumer Internet Resource Management Surgical Devices Venture Debt Bridge Financing Energy Efficiency Technologies Energy Technology Industry Financings Growth Capital Financing Solutions Non Control Financing Solutions Security Software Technology Acquisition
Is HTGX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 25.77
52 Week Low 24.5
Average Volume 3,548
200-Day Moving Average 25.1804
50-Day Moving Average 25.0379
20-Day Moving Average 25.0276
10-Day Moving Average 25.052
Average True Range 0.0724
ADX 16.78
+DI 24.8912
-DI 25.9889
Chandelier Exit (Long, 3 ATRs ) 25.0428
Chandelier Exit (Short, 3 ATRs ) 25.0172
Upper Bollinger Band 25.1341
Lower Bollinger Band 24.9211
Percent B (%b) 0.61
BandWidth 0.85106
MACD Line 0.0084
MACD Signal Line 0.0016
MACD Histogram 0.0068
Fundamentals Value
Market Cap 259.02 Million
Num Shares 10.3 Million
EPS 0.71
Price-to-Earnings (P/E) Ratio 35.48
Price-to-Sales 1.69
Price-to-Book 2.52
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.05
Resistance 3 (R3) 25.05 25.05 25.05
Resistance 2 (R2) 25.05 25.05 25.05 25.05
Resistance 1 (R1) 25.05 25.05 25.05 25.05 25.05
Pivot Point 25.05 25.05 25.05 25.05 25.05
Support 1 (S1) 25.05 25.05 25.05 25.05 25.05
Support 2 (S2) 25.05 25.05 25.05 25.05
Support 3 (S3) 25.05 25.05 25.05
Support 4 (S4) 25.05